help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 48, No. 4 585-593
doi:10.1210/jcem-48-4-585
Copyright © 1979 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LLOYD, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LLOYD, R. V.

Studies on the Progesterone Receptor Content and Steroid Metabolism in Normal and Pathological Human Breast Tissues*

RICARDO V. LLOYD{dagger}

Department of Pathology, University of Wisconsin Hospitals, Madison, Wisconsin 53706

Breast tissues from 44 patients who had normal tissues (9) or pathologic tissues designated as fibrocystic disease (8), fibroadenoma (1), and carcinoma (26) were examined for receptor content and metabolism of progesterone. The last 7-consecutive cases of carcinoma were also examined for testosterone metabolism. When the dextran-coated charcoal assay technique was used to analyze the progesterone receptor content of the cytosols, 3 of 9 normal breast tissues (33%), 1 of 8 tissues with fibrocystic disease (12%), and 10 of 26 breast carcinomas (38%) had progesterone receptor levels greater than 10 fmol/mg protein. In the presence of 30% glycerol and 1 µM cortisol, the dissociation constant for the [3H]progesterone-receptor complex was 1.9 ± 1.1 (SE) nM. Although 4 of 5 cases analyzed by sucrose density gradient sedimentation showed only a 4S peak for the progesterone receptor complex, 1 of 5 cases studied with [3H]progesterone and the 2 cases studied with [3H]R5020 (3Hlabeled 17{alpha},21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione) had radioactive peaks in the 7-8S and the 4S regions of the sucrose gradients.

After incubation of minced tissues with [3H]progesterone, 5{alpha} pregnane-3,20-dione, 3{alpha}-hydroxy-5{alpha}-pregnan-20-one, 20{alpha}-hydroxy-pregn-4-en-3-one, 20{alpha}-hydroxy-5{alpha}-pregnan-3-one, and 5{alpha} pregnane-3{alpha}-20{alpha}-diol were found, indicating the presence of 5{alpha} reductase, 20{alpha}-hydroxysteroid dehydrogenase, and 3{alpha}-hydroxysteroid dehydrogenase activities. Normal breast tissues had the lowest levels of all three enzyme activities, while tissues with fibrocystic disease had the highest 5{alpha}-reductase activity. Carcinoma tissues had intermediate levels of 5{alpha}-reductase and the highest levels of the other two enzyme activities. There was increased production of 5{alpha}-reduced metabolites with increasing epithelial cellularity.

After incubation of breast carcinoma tissues with [3H]testosterone, 5{alpha}-androstane-3{alpha}, 17β-diol, 17β-hydroxy-5{alpha}-androstan-3-one, and androstenedione were found. The presence of NADPH in the incubation medium increased the amounts of 5{alpha} reduced products formed.

5{alpha}-Dihydroprogesterone, the principal metabolite of progesterone in these studies, competed for the progesterone receptor in 2-h competition studies using the dextran-coated charcoal method, but with lower affinity than R5020 or progesterone.

These results indicate that detectable levels of progesterone receptors are present in normal as well as pathologic breast tissues and that 5a-reductase and other enzyme activities are present in variable amounts in different types of breast tissues. (J Clin Endocrinol Metab 48: 585, 1979)

* This work was supported by PHS Grant 5T32-GM-07194-03 and Institutional Research Grant IN-35-Q.

{dagger} Recipient of a fellowship from the American Cancer Society.

Received September 7, 1978.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
J. P Wiebe
Progesterone metabolites in breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 717 - 738.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. P. Wiebe, D. Muzia, J. Hu, D. Szwajcer, S. A. Hill, and J. L. Seachrist
The 4-Pregnene and 5{{alpha}}-Pregnane Progesterone Metabolites Formed in Nontumorous and Tumorous Breast Tissue Have Opposite Effects on Breast Cell Proliferation and Adhesion
Cancer Res., February 1, 2000; 60(4): 936 - 943.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society